Oxford Bioscience Partners

Oxford Bioscience Partners is a venture capital firm specializing in equity financing to advanced-stage start-ups and later-stage commercially oriented organizations and also makes seed capital investments in selective situations. The firm typically invests in companies engaged in genomics and gene-driven technologies, which have transformed the process by which disease targets are identified and drugs are developed; emerging bioscience sectors that are integrating technologies form other industries; in-silico biology that applies computer modeling software to simulate real time functioning of human organs; medical device sector, with a focus on cardiology and urology; and biotechnology with a focus on companies which use technology for life science applications. The firm prefers to invest between $1 million and $7 million. It acts as the lead investor in transactions and also takes a board seat in its portfolio companies. Oxford Bioscience Partners was founded in 1990 and is based in Boston, Massachusetts with additional offices in Westport, Connecticut and Costa Mesa, California.